Granules India achieves First-to-File status for generic Lumryz tablets in the US, enhancing its position in complex generics.
SENSEX 78,130.31
+ 366.40
NIFTY 24,382.00
+ 111.15
CRUDEOIL 6,559.00
Granules India secures sole FTF status for Sodium Oxybate ER, enhancing its position in the complex generics market.
Zydus receives USFDA approval for a surgical imaging drug, Indocyanine Green, with a 180-day exclusivity window for marketing.
Granules India reports a 60% rise in Q1 net profit to ₹180 crore, driven by complex generics and international markets.
GVRP and StepsBio establish a Bengaluru CoE for advanced formulations R&D, enhancing drug delivery systems and sterile…
Granules India reports a 60% net profit increase to ₹180 crore and 22% revenue growth in Q1 fiscal 2026.
Alembic Pharmaceuticals receives USFDA approval for generic Dapsone gel, a topical acne treatment equivalent to Aczone.
